Literature DB >> 2329368

Autoradiographical detection of cholecystokinin-A receptors in primate brain using 125I-Bolton Hunter CCK-8 and 3H-MK-329.

D R Hill1, T M Shaw, W Graham, G N Woodruff.   

Abstract

In vitro autoradiography was performed in order to visualize cholecystokinin-A (CCK-A) receptors in sections of Cynomolgus monkey brain. CCK-A receptors were defined as those which displayed high affinity for the selective non-peptide antagonist MK-329 (L-364,718) and were detected in several regions by selective inhibition of 125I-Bolton Hunter CCK using MK-329 or direct labeling with 3H-MK-329. In the caudal medulla, high densities of CCK-A sites were present in the nucleus tractus solitarius, especially the caudal and medial aspects, and also the dorsal motor nucleus of the vagus. CCK-A sites were localized to a number of hypothalamic nuclei such as the supraoptic and paraventricular nuclei, the dorsomedial and infundibular nuclei as well as the neurohypophysis. The mammillary bodies and supramammillary nuclei also contained CCK-A receptor sites. High concentrations of CCK-A receptors were present in the substantia nigra zona compacta and also the ventral tegmental area and may be associated with dopamine cell bodies. Binding of 3H-MK-329 was also detected in parts of the caudate nucleus and ventral putamen. The detection, by autoradiographical means, of CCK-A receptors throughout the Cynomolgus monkey brain contrasts with similar studies performed using rodents and suggests differences in the density and, perhaps, the importance of CCK-A receptors in the primate as opposed to the rodent. The data suggest the possibility that CCK-A receptors may be involved in a number of important brain functions as diverse as the processing of sensory information from the gut, the regulation of hormone secretion, and the activity of dopamine cell activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2329368      PMCID: PMC6570219     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  19 in total

1.  Requirement of phospholipase C and protein kinase C in cholecystokinin-mediated facilitation of NMDA channel function and anxiety-like behavior.

Authors:  Zhaoyang Xiao; Manoj K Jaiswal; Pan-Yue Deng; Toshimitsu Matsui; Hee-Sup Shin; James E Porter; Saobo Lei
Journal:  Hippocampus       Date:  2011-11-10       Impact factor: 3.899

2.  Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression.

Authors:  S A Wank; J R Pisegna; A de Weerth
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

3.  Phospholipase C not protein kinase C is required for the activation of TRPC5 channels by cholecystokinin.

Authors:  Laurel A Grisanti; Lalitha Kurada; Nicholas I Cilz; James E Porter; Saobo Lei
Journal:  Eur J Pharmacol       Date:  2012-06-07       Impact factor: 4.432

4.  Cholecystokinin facilitates neuronal excitability in the entorhinal cortex via activation of TRPC-like channels.

Authors:  Shouping Wang; An-Ping Zhang; Lalitha Kurada; Toshimitsu Matsui; Saobo Lei
Journal:  J Neurophysiol       Date:  2011-07-13       Impact factor: 2.714

5.  In vitro analysis of the effects of cholecystokinin on rat brain stem motoneurons.

Authors:  Zhongling Zheng; Mark W Lewis; R Alberto Travagli
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-12-09       Impact factor: 4.052

6.  Cholecystokinin facilitates glutamate release by increasing the number of readily releasable vesicles and releasing probability.

Authors:  Pan-Yue Deng; Zhaoyang Xiao; Archana Jha; David Ramonet; Toshimitsu Matsui; Michael Leitges; Hee-Sup Shin; James E Porter; Jonathan D Geiger; Saobo Lei
Journal:  J Neurosci       Date:  2010-04-14       Impact factor: 6.167

7.  Cholecystokinin and psychiatric disorders : role in aetiology and potential of receptor antagonists in therapy.

Authors:  J Shlik; E Vasar; J Bradwejn
Journal:  CNS Drugs       Date:  1997-08       Impact factor: 5.749

8.  PD-136,450: a CCK2 (gastrin) receptor antagonist with antisecretory, anxiolytic and antiulcer activity.

Authors:  S M A Bastaki; M Y Hasan; S I Chandranath; A Schmassmann; A Garner
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

9.  Electrical stimulation of the prefrontal cortex increases cholecystokinin, glutamate, and dopamine release in the nucleus accumbens: an in vivo microdialysis study in freely moving rats.

Authors:  Z B You; T M Tzschentke; E Brodin; R A Wise
Journal:  J Neurosci       Date:  1998-08-15       Impact factor: 6.167

10.  Influences of cholecystokinin octapeptide on phosphoinositide turnover in neonatal-rat brain cells.

Authors:  L J Zhang; X Y Lu; J S Han
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.